These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 4219256)

  • 1. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
    Loubatières A; Loubatières-Mariani MM
    Endocrinol Exp; 1974 Jun; 8(2):75-87. PubMed ID: 4209693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 6. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
    Mariani MM
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 9. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.
    Samols E; Weir GC; Ramseur R; Day JA; Patel YC
    Metabolism; 1978 Sep; 27(9 Suppl 1):1219-21. PubMed ID: 682983
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin secretion studied on isolated perfused rat pancreas. II. Effects of catecholamines and adrenergic blocking drugs].
    Loubatières A; Mariani MM; Chapal J
    Diabetologia; 1970 Dec; 6(6):533-41. PubMed ID: 4395476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synergetic action between glucose and hypotlycemic sulfamides on insulin secretion].
    Loubatières A; Mariani MM; Chapal J
    C R Acad Hebd Seances Acad Sci D; 1968 Jul; 267(1):123-6. PubMed ID: 4971521
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
    Seltzer HS; Crout JR
    Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
    Basabe JC; Lopez NL; Viktora JK; Wolff FW
    Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of thiazides upon insulin secretion in vitro.
    Malaisse W; Malaisse-Legae F
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):235-9. PubMed ID: 4868989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
    Loubatières A; Mariani MM; Chapal J
    C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.
    Loubatières-Mariani MM; Loubatières AL; Chapal J
    Diabetologia; 1973 Apr; 9(2):152-7. PubMed ID: 4716116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.